Kevin Michael Krause's Net Worth
$0
Who is Kevin Michael Krause?
Kevin Michael Krause does not have any significant net worth to report based on the numbers we have. This is based on reported shares in AN2 Therapeutics, Inc..
SEC CIK
Kevin Michael Krause's CIK is 0001916925
Past Insider Trading and Trends
2022 was Kevin Michael Krause's most active year for acquiring shares with 1 total transactions. Kevin Michael Krause's most active month to acquire stocks was the month of January. 2022 saw Kevin Michael Krause paying a total of $0.00 for 66,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $19.975
Chief Strategy Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1,567.40% | 30K |
—
|
—
| 31.91K |
Mar 15
| |||
Form 4
| +1,567.40% | 30K |
—
|
—
| 31.91K |
Mar 15
| |||
Form 4
|
—
|
0
|
$12.37 | -$115,352.11 | 1.91K |
Jan 9
| |||
Form 4
|
—
|
0
|
$10.27 | -$50,882.26 | 1.91K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||